122 related articles for article (PubMed ID: 16951349)
1. Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility.
Green MR; Yoon H; Boss JM
J Immunol; 2006 Sep; 177(6):3865-73. PubMed ID: 16951349
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
[TBL] [Abstract][Full Text] [Related]
4. E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).
van der Stoep N; Quinten E; Marcondes Rezende M; van den Elsen PJ
Blood; 2004 Nov; 104(9):2849-57. PubMed ID: 15242870
[TBL] [Abstract][Full Text] [Related]
5. PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA.
Yoon H; Boss JM
J Immunol; 2010 May; 184(9):5018-28. PubMed ID: 20363966
[TBL] [Abstract][Full Text] [Related]
6. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
[TBL] [Abstract][Full Text] [Related]
8. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.
Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C
PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023
[TBL] [Abstract][Full Text] [Related]
9. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
[TBL] [Abstract][Full Text] [Related]
10. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.
Holling TM; van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Jan; 168(2):763-70. PubMed ID: 11777970
[TBL] [Abstract][Full Text] [Related]
11. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
[TBL] [Abstract][Full Text] [Related]
12. HIC1 epigenetically represses CIITA transcription in B lymphocytes.
Zeng S; Yang Y; Cheng X; Zhou B; Li P; Zhao Y; Kong X; Xu Y
Biochim Biophys Acta; 2016 Dec; 1859(12):1481-1489. PubMed ID: 27720955
[TBL] [Abstract][Full Text] [Related]
13. Common distal elements orchestrate CIITA isoform-specific expression in multiple cell types.
Lohsen S; Majumder P; Scharer CD; Barwick BG; Austin JW; Zinzow-Kramer WM; Boss JM
Genes Immun; 2014 Dec; 15(8):543-55. PubMed ID: 25101797
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
15. DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.
Murphy SP; Holtz R; Lewandowski N; Tomasi TB; Fuji H
J Immunol; 2002 Sep; 169(6):3085-93. PubMed ID: 12218125
[TBL] [Abstract][Full Text] [Related]
16. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
17. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
[TBL] [Abstract][Full Text] [Related]
19. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
Nakano N; Nishiyama C; Yagita H; Koyanagi A; Ogawa H; Okumura K
J Biol Chem; 2011 Apr; 286(14):12042-8. PubMed ID: 21321116
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
